These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1579899)

  • 1. Effects of polyclonal antibodies against conjugated L-dopa or against conjugated acetylcholine on experimental venous thrombosis.
    Lagier B; Charrier MC; Geffard M; Doutremepuich C
    Thromb Res; 1992 Jan; 65(2):275-80. PubMed ID: 1579899
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of monoclonal and polyclonal antibodies against conjugated neurotransmitter on experimental venous thrombosis.
    Belougne E; Lagier B; Doutremepuich F; Doutremepuich C
    Semin Thromb Hemost; 1996; 22 Suppl 1():49-52. PubMed ID: 8807729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of a specific antibody for the immunohistochemical detection of L-dopa in paraformaldehyde-fixed rodent brains.
    Mons N; Dubourg P; Tramu G
    Brain Res; 1991 Jul; 554(1-2):122-9. PubMed ID: 1681987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of L-dopa immunoreactive neurons in the rat preoptic area and anterior hypothalamus.
    Mons N; Tison F; Geffard M
    Neuroendocrinology; 1990 Apr; 51(4):425-8. PubMed ID: 2111889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-conjugated acetylcholine antibody and immunohistochemical applications in rat nervous system.
    Chagnaud JL; Souan ML; Charrier MC; Geffard M
    J Neurochem; 1989 Aug; 53(2):383-91. PubMed ID: 2746227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of anticardiolipin antibodies in the pathogenesis of arterial and venous thromboses].
    Eber B
    Acta Med Austriaca; 1990; 17(4):67-70. PubMed ID: 2291381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous L-dopa in the rat dorsal vagal complex: an immunocytochemical study by light and electron microscopy.
    Tison F; Mons N; Rouet-Karama S; Geffard M; Henry P
    Brain Res; 1989 Sep; 497(2):260-70. PubMed ID: 2819424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats.
    Ueda H; Sato K; Okumura F; Misu Y
    Brain Res; 1995 Nov; 698(1-2):213-6. PubMed ID: 8581484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.
    Ginsburg KS; Liang MH; Newcomer L; Goldhaber SZ; Schur PH; Hennekens CH; Stampfer MJ
    Ann Intern Med; 1992 Dec; 117(12):997-1002. PubMed ID: 1443986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
    DeBoer P; Abercrombie ED; Heeringa M; Westerink BH
    Brain Res; 1993 Apr; 608(2):198-203. PubMed ID: 8495354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
    Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of L-dopa-dopamine and L-dopa cell bodies in the rat mesencephalic dopaminergic cell systems.
    Mons N; Tison F; Geffard M
    Synapse; 1989; 4(2):99-105. PubMed ID: 2781469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure of receptors and expression of anti-receptor antibodies. b. Anti-acetylcholine receptor antibodies].
    Takamori M; Okumura S; Nagata M
    Nihon Rinsho; 1988 Apr; 46(4):816-21. PubMed ID: 3261359
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
    Sabel BA; Dominiak P; Häuser W; During MJ; Freese A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):914-22. PubMed ID: 2243358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of a specific antibody to each one of catecholamines and L-DOPA.
    Miwa A; Yoshioka M; Shirahata A; Nakagawa Y; Tamura Z
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1422-4. PubMed ID: 1035514
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of specific antibody against L-dopa and its ultrastructural localization of immunoreactivity in the house-shrew (Suncus murinus) lateral habenular nucleus.
    Karasawa N; Isomura G; Nagatsu I
    Neurosci Lett; 1992 Aug; 143(1-2):267-70. PubMed ID: 1359476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic L-dopa administration decreases striatal accumulation of dopamine from exogenous L-dopa in rats with intact nigrostriatal projections.
    Melamed E; Globus M; Friedlender E; Rosenthal J
    Neurology; 1983 Jul; 33(7):950-3. PubMed ID: 6683384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deep venous thrombosis of inferior extremity in a patient with AIDS and anticardiolipin antibodies].
    Orbea Ríos L; Venero Gómez J; Justo Alpañés E; Colmenero Camacho M; Rodríguez Piñero J
    An Med Interna; 1999 May; 16(5):268. PubMed ID: 10389322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.